Eagle Pharmaceuticals
EGRX
#11116
Rank
NZ$6.01 M
Marketcap
NZ$0.46
Share price
0.00%
Change (1 day)
-67.24%
Change (1 year)

EPS for Eagle Pharmaceuticals (EGRX)

EPS in 2023 (TTM): NZ$1.85

According to Eagle Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$2.18. In 2022 the company made an earnings per share (EPS) of NZ$5.65 an increase over its 2021 EPS that were of NZ-$1.21.

EPS history for Eagle Pharmaceuticals from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)NZ$1.85-67.22%
2022NZ$5.65-568.18%
2021NZ-$1.21
2019NZ$1.88-52.75%
2018NZ$3.99-36.63%
2017NZ$6.29-35.09%
2016NZ$9.691792.86%
2015NZ$0.51-117.39%
2014NZ-$2.94

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$12.21 461.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$9.60 341.18%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
NZ$56.47 2,495.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$31.77 1,360.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$8.26 279.83%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$5.26 141.79%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
NZ$0.82-62.18%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel